Security key
71880W501
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)
CUSIP: 71880W501
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 28,506
- Total 13F value
- $98,345
- Share change
- +28,506
- SEC-reported price per share
- $3.45
- Number of holders
- 6
- Value change
- +$98,345
- Number of buys
- 6
- Shares outstanding
- 12,067,869
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
6
Top holders
6
PHIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71880W501
Recent filing periods:
Ownership snapshot
Top reported holders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gerrit Dispersyn
Disclosed value leader
Gerrit Dispersyn
Comparable rows
0/15
Latest evidence
11 Sep 2024
3/4/5
13F
Highest disclosed value: $320,614
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Gerrit Dispersyn has the largest disclosed position value at $320.6K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Gerrit Dispersyn's linked filing trail.
Disclosed position value
Top 5
Gerrit Dispersyn
$320.6K
H. Paul Dorman
$30.8K
Cetera Investment Advisers
$24.5K
GEODE CAPITAL MANAGEMENT, LLC
$19.7K
VANGUARD GROUP INC
$16.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gerrit Dispersyn |
3/4/5
President & CEO, Director
|
—
class O/S missing
|
$320,614
212,327 shares
|
— | 01 Mar 2022 |
| H. Paul Dorman |
3/4/5
Director
|
—
class O/S missing
|
$30,759
20,370 shares
|
— | 15 Feb 2022 |
| Cetera Investment Advisers |
13F
Company
|
—
class O/S missing
|
$24,504
35,416 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$19,662
28,136 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$16,869
24,380 shares
|
— | 30 Jun 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$16,412
23,486 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
28,506
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
17
Q3 2024 holders
6
Holder diff
-11
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend